BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24277454)

  • 1. Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
    Gramatges MM; Liu Q; Yasui Y; Okcu MF; Neglia JP; Strong LC; Armstrong GT; Robison LL; Bhatia S
    Clin Cancer Res; 2014 Feb; 20(4):904-11. PubMed ID: 24277454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short NK- and Naïve T-Cell Telomere Length Is Associated with Thyroid Cancer in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study.
    Man TK; Aubert G; Richard MA; LeJeune W; Hariri E; Goltsova T; Gaikwad A; Chen Y; Whitton J; Leisenring WM; Arnold MA; Neglia JP; Yasui Y; Robison LL; Armstrong GT; Bhatia S; Gramatges MM
    Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):453-460. PubMed ID: 34782395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
    Richard MA; Lupo PJ; Morton LM; Yasui YA; Sapkota YA; Arnold MA; Aubert G; Neglia JP; Turcotte LM; Leisenring WM; Sampson JN; Chanock SJ; Hudson MM; Armstrong GT; Robison LL; Bhatia S; Gramatges MM
    PLoS One; 2020; 15(2):e0228887. PubMed ID: 32040538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere Length-Associated Genetic Variants and the Risk of Thyroid Cancer in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study (CCSS).
    Gramatges MM; Morton LM; Yasui Y; Arnold MA; Neglia JP; Leisenring WM; Machiela MJ; Dagnall CL; Chanock SJ; Armstrong GT; Robison LL; Bhatia S; Lupo PJ
    Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):417-419. PubMed ID: 30377209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
    J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study.
    Henderson TO; Rajaraman P; Stovall M; Constine LS; Olive A; Smith SA; Mertens A; Meadows A; Neglia JP; Hammond S; Whitton J; Inskip PD; Robison LL; Diller L
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):224-30. PubMed ID: 22795729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
    J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
    O'Brien MM; Donaldson SS; Balise RR; Whittemore AS; Link MP
    J Clin Oncol; 2010 Mar; 28(7):1232-9. PubMed ID: 20124178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort.
    Teepen JC; Kremer LC; van der Heiden-van der Loo M; Tissing WJ; van der Pal HJ; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Versluys B; van Dulmen-den Broeder E; Visser O; Maduro JH; van Leeuwen FE; Ronckers CM;
    Cancer Causes Control; 2019 Sep; 30(9):909-922. PubMed ID: 31300947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.
    Neglia JP; Friedman DL; Yasui Y; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL
    J Natl Cancer Inst; 2001 Apr; 93(8):618-29. PubMed ID: 11309438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are short telomeres hallmarks of cancer recurrence?
    Shay JW
    Clin Cancer Res; 2014 Feb; 20(4):779-81. PubMed ID: 24366690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
    Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
    JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study Report.
    Im C; Sharafeldin N; Yuan Y; Wang Z; Sapkota Y; Lu Z; Spector LG; Howell RM; Arnold MA; Hudson MM; Ness KK; Robison LL; Bhatia S; Armstrong GT; Neglia JP; Yasui Y; Turcotte LM
    J Clin Oncol; 2023 Sep; 41(27):4381-4393. PubMed ID: 37459583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
    Henderson TO; Oeffinger KC; Whitton J; Leisenring W; Neglia J; Meadows A; Crotty C; Rubin DT; Diller L; Inskip P; Smith SA; Stovall M; Constine LS; Hammond S; Armstrong GT; Robison LL; Nathan PC
    Ann Intern Med; 2012 Jun; 156(11):757-66, W-260. PubMed ID: 22665813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
    Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study.
    Guérin S; Hawkins M; Shamsaldin A; Guibout C; Diallo I; Oberlin O; Brugières L; de Vathaire F
    J Clin Oncol; 2007 Jul; 25(19):2833-9. PubMed ID: 17602088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Marina NM; Liu Q; Donaldson SS; Sklar CA; Armstrong GT; Oeffinger KC; Leisenring WM; Ginsberg JP; Henderson TO; Neglia JP; Stovall MA; Yasui Y; Randall RL; Geller DS; Robison LL; Ness KK
    Cancer; 2017 Jul; 123(13):2551-2560. PubMed ID: 28222219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subsequent neoplasms in childhood cancer survivors.
    Zichová A; Eckschlager T; Ganevová M; Malinová B; Lukš A; Kruseová J
    Cancer Epidemiol; 2020 Oct; 68():101779. PubMed ID: 32682319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
    Nguyen F; Rubino C; Guerin S; Diallo I; Samand A; Hawkins M; Oberlin O; Lefkopoulos D; De Vathaire F
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):908-15. PubMed ID: 18262102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.